NCT00140673 - A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants. | Biotech Hunter

Enrollment

63,227

Participants

Timeline

Start Date

August 5, 2003

Study Completion Date

October 20, 2005

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Rotavirus

Trial Locations (17)

GSK Investigational Site, Durango

GSK Investigational Site, Villanueva

GSK Investigational Site, Tampere

GSK Investigational Site, Tlanepantla

GSK Investigational Site, Belém

GSK Investigational Site, Valparaíso

GSK Investigational Site, Concepción

GSK Investigational Site, Cali Colombia

GSK Investigational Site, Santo Domingo

GSK Investigational Site, Tegucigalpa

GSK Investigational Site, Cuernavaca

GSK Investigational Site, León

GSK Investigational Site, Panama City

GSK Investigational Site, Valencia

GSK Investigational Site, Mexico City

GSK Investigational Site, México

GSK Investigational Site, Lima